Related Experiment Videos
Beta-lactamase activity in ampicillin-resistant Haemophilus influenzae
Antimicrobial Agents and Chemotherapy
|November 1, 1974
Summary
This study investigated the beta-lactamase enzyme from ampicillin-resistant Haemophilus influenzae type B. The enzyme
Area of Science:
- Microbiology
- Enzymology
- Antibiotic Resistance
Background:
- Haemophilus influenzae type B is a significant pathogen.
- Antibiotic resistance in bacteria is a growing public health concern.
- Beta-lactamase enzymes are a key mechanism of resistance to beta-lactam antibiotics.
Purpose of the Study:
- To characterize the beta-lactamase enzyme produced by an ampicillin-resistant strain of Haemophilus influenzae type B.
- To compare this enzyme to beta-lactamases from other bacterial species.
- To determine the role of this beta-lactamase in the organism's antibiotic resistance.
Main Methods:
- Investigated enzyme activity, substrate profile, inhibitor response, inducibility, and cellular localization.
- Compared enzyme properties to known beta-lactamases.
- Correlated enzyme characteristics with minimal inhibitory concentrations of antibiotics.
Main Results:
- The enzyme's properties resemble those of beta-lactamases from Gram-negative bacilli, particularly Klebsiella pneumoniae.
- It differs significantly from beta-lactamases found in other Gram-negative bacteria.
- The enzyme's substrate profile suggests a significant role in ampicillin resistance.
Conclusions:
- The beta-lactamase from Haemophilus influenzae type B is distinct and plays a crucial role in antibiotic resistance.
- Understanding this enzyme can inform strategies against resistant bacterial infections.